ArchiveSee matrix →ES
Mechanism

Testosterone

Main androgen produced in Leydig cells (testes) and in smaller amounts in the ovaries and adrenals. Regulates libido, muscle mass, bone density, erythropoiesis, spatial cognition, and mood. It declines 1-2% per year from age 30-40; its deficiency produces hypogonadism with physical and psychological symptoms.
Category
Scientific evidence
Very high
Number of findings
4
Sources
Our own summaries · Cited studies

Effect by goal · level of evidence

Libido and sexual function

regulates Very high physiology (AAA)
Hypogonadism target

Low levels are associated with sexual hypoactivity and erectile dysfunction. Replacement therapy improves libido and erections in biochemically confirmed hypogonadism.

View the study (meta-analysis) →

Muscle mass and strength

regulates Very high physiology (A)
Muscle anabolism

Direct muscle anabolism. Decline with age contributes to sarcopenia. Strength exercise is the most potent endogenous stimulus for maintaining it.

View the study (review) →

Mood and energy

modulates Moderate observational (A)
Depression pathway

Deficiency is associated with fatigue, irritability, apathy, and treatment-resistant depression. Replacement in hypogonadism improves mood; in normogonadism the effect is uncertain.

View the study (systematic review) →

Cardiovascular health

controversy Moderate mixed cohorts (AA)
U-shaped curve

Observational data suggest a U-shaped association: very low and very high levels are associated with more events. Replacement therapy requires strict clinical judgment.

Information, not medical advice. Scientific evidence reflects the quality of the studies.

Loading assistant…